OSTEONIC Co., Ltd. (KOSDAQ: 226400)
South Korea
· Delayed Price · Currency is KRW 5,130.00
-10.00 (-0.19%)
Nov 15, 2024, 9:00 AM KST
OSTEONIC Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Operating Revenue | 32,543 | 27,799 | 19,839 | 15,598 |
| Other Revenue | -0 | - | -0 | -0 |
| Revenue | 32,543 | 27,799 | 19,839 | 15,598 |
| Revenue Growth (YoY) | 25.30% | 40.12% | 27.19% | - |
| Cost of Revenue | 16,777 | 14,838 | 11,195 | 9,151 |
| Gross Profit | 15,766 | 12,960 | 8,644 | 6,446 |
| Selling, General & Admin | 7,154 | 6,950 | 5,690 | 4,403 |
| Research & Development | 1,915 | 1,254 | 454.15 | 255.78 |
| Other Operating Expenses | 115.88 | 99.19 | 172.76 | 136.06 |
| Operating Expenses | 8,929 | 8,118 | 6,118 | 5,867 |
| Operating Income | 6,837 | 4,843 | 2,526 | 579.41 |
| Interest Expense | -795.29 | -756.43 | -1,373 | -1,606 |
| Interest & Investment Income | 314.62 | 369.62 | 213.85 | 151.64 |
| Currency Exchange Gain (Loss) | -263.1 | 199.59 | 757.69 | 789.97 |
| Other Non Operating Income (Expenses) | -1,965 | -2,370 | 1,970 | -4,528 |
| EBT Excluding Unusual Items | 4,128 | 2,285 | 4,094 | -4,614 |
| Gain (Loss) on Sale of Investments | 215.73 | -8.84 | -622.33 | -244.81 |
| Gain (Loss) on Sale of Assets | 5.18 | 1.33 | 4.72 | -65.24 |
| Asset Writedown | -86.75 | -496.63 | -1,373 | -513.88 |
| Other Unusual Items | - | - | -22.42 | - |
| Pretax Income | 4,262 | 1,781 | 2,081 | -5,438 |
| Income Tax Expense | -1,919 | -1,877 | 1,245 | -2,586 |
| Net Income | 6,181 | 3,658 | 835.53 | -2,852 |
| Net Income to Common | 6,181 | 3,658 | 835.53 | -2,852 |
| Net Income Growth | 1214.41% | 337.77% | - | - |
| Shares Outstanding (Basic) | 20 | 19 | 17 | 16 |
| Shares Outstanding (Diluted) | 20 | 19 | 21 | 16 |
| Shares Change (YoY) | -10.63% | -10.88% | 37.15% | - |
| EPS (Basic) | 308.69 | 193.12 | 49.94 | -182.75 |
| EPS (Diluted) | 306.65 | 191.77 | 4.67 | -183.00 |
| EPS Growth | - | 4003.04% | - | - |
| Free Cash Flow | -2,874 | -1,968 | 3,504 | 2,006 |
| Free Cash Flow Per Share | -142.58 | -103.17 | 163.72 | 128.57 |
| Gross Margin | 48.45% | 46.62% | 43.57% | 41.33% |
| Operating Margin | 21.01% | 17.42% | 12.73% | 3.71% |
| Profit Margin | 18.99% | 13.16% | 4.21% | -18.28% |
| Free Cash Flow Margin | -8.83% | -7.08% | 17.66% | 12.86% |
| EBITDA | 10,086 | 7,550 | 4,942 | 2,793 |
| EBITDA Margin | 30.99% | 27.16% | 24.91% | 17.90% |
| D&A For EBITDA | 3,249 | 2,707 | 2,415 | 2,213 |
| EBIT | 6,837 | 4,843 | 2,526 | 579.41 |
| EBIT Margin | 21.01% | 17.42% | 12.73% | 3.71% |
| Effective Tax Rate | - | - | 59.85% | - |
| Advertising Expenses | - | 422.53 | 288.76 | 154.13 |
Source: S&P Capital IQ. Standard template. Financial Sources.